GET THE APP

Medication-related osteonecrosis of the jaw (MRONJ): In

Dental Health: Current Research.ISSN: 2470-0886

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Medication-related osteonecrosis of the jaw (MRONJ): Information for general dental practioners


Tarun Nagpal

King’s College London, UK

: Dent Health Curr Res

Abstract


A justified amount of concern and confusion exists by GDPs in management of patients with a percieved risk of MRONJ. The condition itself when present is a major cause of morbidity and may severely affect the quality of life for some patients. The condition was traditionly associated with the bisphosponate groups of drugs however with the development of numerous other medication potentially causing similar conditions the term MRONJ has been coined.

Biography


Tarun Nagpal qualified from Kings College London in 2016 with a BDS, he then completed his foundation training in Surrey treating a wide array of patients from different demographics. He is a a member of the faculty of dental surgery and has obtained a Postgraduate Diploma in Primary Dental Care. He is in his second year of Oral and Maxillofacial training at Northwick Park Hospital, after completing a year at Kings College Hospital.

E-mail: tarun.nagpal@nhs.net

Track Your Manuscript